Related Experiment Video
Updated: Dec 12, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
Pedram Goodarzi1, Farzad Mahdavi2, Rasoul Mirzaei3
1Faculty of Pharmacy, Iran University of Medical Sciences, Tehran, Iran.
Abstract:
The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to develop antiviral strategies for the treatment of COVID-19 are underway. The rapidly increasing understanding of SARS-CoV-2 virology provides a notable number of possible immunological procedures and drug targets. However, gaps remain in our understanding of the pathogenesis of COVID-19. In this review, we describe the latest information in the context of immunological approaches and emerging current antiviral strategies for COVID-19 treatment.
Insights
Current COVID-19 treatments lack proven effectiveness. This review covers emerging immunological and antiviral strategies to combat the SARS-CoV-2 virus, addressing gaps in understanding its pathogenesis.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes the global COVID-19 pandemic.
- Existing therapies for COVID-19 are not definitively effective.
- Understanding SARS-CoV-2 pathogenesis remains incomplete.
Purpose of the Study:
- To review current knowledge on SARS-CoV-2.
- To highlight emerging immunological approaches for COVID-19 treatment.
- To discuss novel antiviral strategies against SARS-CoV-2.
Main Methods:
- Literature review of recent studies on SARS-CoV-2.
- Analysis of immunological procedures and drug targets.
- Synthesis of information on antiviral strategies.
Main Results:
- Numerous potential immunological targets identified.
- Several promising antiviral drug candidates are emerging.
- Gaps in understanding COVID-19 pathogenesis persist.
Conclusions:
- Continued research into SARS-CoV-2 virology is crucial.
- Development of effective COVID-19 therapies requires further investigation.
- Immunological and antiviral strategies offer potential for future treatments.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

